Published: January 25, 2013 at 12:19 pm

Google Inc. (NASDAQ:GOOG) may still be basking in the success of its quarterly earnings report this week, but it continues to make some news. On this Friday morning, the tech giant is continuing a crusade, while another European country is getting in line on the continent’s own crusade for tax revenue.

LET’S PASS ON THE PASSWORDS

OK, so it isn’t a secret that Google Inc. (NASDAQ:GOOG) has been undergoing a nearly three-year-long battle to eliminate passwords as a system of verification on a majority of Web sites. But a tech writer posted Friday morning that a research paper regarding a protocol for online verification is due out in the next few days, that is designed to shed light on the company’s latest project designed to eliminate the need for passwords.

This latest project is supposedly involves a finger-ring, a piece of authentication hardware and a protocol that would link those pieces to the various web sites. The paper is being prepared by Google Inc. (NASDAQ:GOOG) executive Eric Grosse and engineer Mayank Upadhyay, who are also expected to discuss authentication by a device – like using a smartphone or tablet’s IP address to verify a user’s identity.

GIVE THE SWISS MORE CHEESE!

Various countries in the European Union have targeted multinational companies like Google Inc. (NASDAQ:GOOG) and Amazon.com Inc. (NASDAQ:AMZN), which have legally found loopholes in EU taxation rules to minimize their tax bills in individual countries. Well now, non-EU member Switzerland, which houses the largest Google headquarters outside the U.S., is beginning a push to get more tax revenue from Google. Due to the loopholes, though Google has a headquarters in Zurich, pays “virtually no” corporate taxes to Switzerland, thanks to channeling much of its revenue through more tax-friendly locations.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.